Page last updated: 2024-09-05

6-amidino-2-naphthol and Hyperkalemia

6-amidino-2-naphthol has been researched along with Hyperkalemia in 2 studies

*Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed) [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, Y; Imai, M; Muto, S1
Asano, Y; Furuya, H; Ookawara, S; Sakairi, Y; Sakurai, T; Tabei, K1

Other Studies

2 other study(ies) available for 6-amidino-2-naphthol and Hyperkalemia

ArticleYear
Mechanisms of the hyperkalaemia caused by nafamostat mesilate: effects of its two metabolites on Na+ and K+ transport properties in the rabbit cortical collecting duct.
    British journal of pharmacology, 1994, Volume: 111, Issue:1

    Topics: Animals; Benzamidines; Benzoates; Biological Transport, Active; Dose-Response Relationship, Drug; Electrophysiology; Female; Guanidines; Humans; Hyperkalemia; In Vitro Techniques; Infant, Newborn; Kidney Tubules, Collecting; Membrane Potentials; Microelectrodes; Naphthols; Phenobarbital; Potassium; Rabbits; Serine Proteinase Inhibitors; Sodium

1994
Additional mechanisms of nafamostat mesilate-associated hyperkalaemia.
    European journal of clinical pharmacology, 1996, Volume: 51, Issue:2

    Topics: Adult; Benzamidines; Benzoates; Erythrocytes; Guanidines; Humans; Hyperkalemia; In Vitro Techniques; Naphthols; Potassium; Protease Inhibitors; Sodium-Potassium-Exchanging ATPase

1996